| Product Code: ETC12773469 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
Despite a high concentration of import shipments from top countries like India, China, and the USA, Nigeria`s NSAIDs import market saw a significant decline with a CAGR of -26.13% from 2020 to 2024. The growth rate in 2024 decreased by -30.33%, indicating a challenging market environment. However, the diverse range of exporting countries, including the Netherlands and Metropolitan France, offers opportunities for market expansion and increased competition in the future. Monitoring market trends and adapting strategies will be crucial for stakeholders in the Nigerian NSAIDs import market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Overview |
3.1 Nigeria Country Macro Economic Indicators |
3.2 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, 2021 & 2031F |
3.3 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Industry Life Cycle |
3.4 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Porter's Five Forces |
3.5 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as arthritis and musculoskeletal disorders in Nigeria |
4.2.2 Growing awareness about the benefits of non-steroidal anti-inflammatory drugs (NSAIDs) among healthcare professionals and patients |
4.2.3 Rising geriatric population in Nigeria, who are more prone to inflammatory conditions that require NSAID treatment |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines governing the use and distribution of NSAIDs in Nigeria |
4.3.2 Concerns regarding potential side effects and adverse reactions associated with long-term use of NSAIDs |
4.3.3 Limited access to healthcare facilities and affordability issues for some segments of the population in Nigeria |
5 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Trends |
6 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Types |
6.1 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By OTC NSAIDs, 2021 - 2031F |
6.1.4 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Prescription NSAIDs, 2021 - 2031F |
6.1.5 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Topical NSAIDs, 2021 - 2031F |
6.1.6 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Ibuprofen, 2021 - 2031F |
6.2.3 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Celecoxib, 2021 - 2031F |
6.2.4 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Diclofenac Gel, 2021 - 2031F |
6.2.5 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Naproxen, 2021 - 2031F |
6.3 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.3 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.4 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.5 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Homecare, 2021 - 2031F |
6.4 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Pain Relief, 2021 - 2031F |
6.4.3 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Arthritis Treatment, 2021 - 2031F |
6.4.4 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Musculoskeletal Pain, 2021 - 2031F |
6.4.5 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenues & Volume, By Fever Reduction, 2021 - 2031F |
7 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Import-Export Trade Statistics |
7.1 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Export to Major Countries |
7.2 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Imports from Major Countries |
8 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Key Performance Indicators |
8.1 Number of prescriptions for NSAIDs issued by healthcare providers in Nigeria |
8.2 Patient adherence rates to NSAID treatment regimens |
8.3 Frequency of adverse events reported related to NSAID use |
8.4 Percentage of healthcare professionals recommending NSAIDs as a first-line treatment option for inflammatory conditions |
8.5 Market penetration rate of different types of NSAIDs in Nigeria |
9 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Opportunity Assessment |
9.1 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market - Competitive Landscape |
10.1 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Revenue Share, By Companies, 2024 |
10.2 Nigeria Non Steroidal Anti Inflammatory Drugs NSAIDs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |